PAULA HERTEL to Non-alcoholic Fatty Liver Disease
This is a "connection" page, showing publications PAULA HERTEL has written about Non-alcoholic Fatty Liver Disease.
Connection Strength
0.547
-
Renal impairment is prevalent in pediatric NAFLD/MASLD and associated with disease severity. J Pediatr Gastroenterol Nutr. 2024 Aug; 79(2):238-249.
Score: 0.149
-
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease. Hepatology. 2024 06 01; 79(6):1381-1392.
Score: 0.143
-
Validation of the accuracy of the FAST? score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms. PLoS One. 2022; 17(4):e0266859.
Score: 0.128
-
Randomized placebo-controlled trial of losartan for pediatric NAFLD. Hepatology. 2022 08; 76(2):429-444.
Score: 0.127